Loading...
Progression free survival is defined as the period from randomization to disease progress or death. Includes first-line induction therapy and maintenance therapy.
Defined as the proportion of participants acquired Complete response (CR) or Partial response (PR) during treatment. Based on RECIST 1.1.
Defined as the proportion of patients who acquired Complete response (CR), Partial response (PR), or Stable disease (SD) during treatment. Based on RECIST 1.1.
Defined as the time from the date of randomization to [secondary disease progression after reintroduction of first-line induction chemotherapy following maintenance therapy disease progression] or [all-cause death]. If participants progressed on maintenance therapy after first-line induction chemotherapy without reintroduction of first-line induction chemotherapy or progressed during first-line induction chemotherapy, TFS equals PFS
Defined as the period from randomization to death from any cause
The rate of adverse event after treatment
Including CERs (Cost-Effectiveness Ratios) and ICERs (Incremental Cost-Effectiveness Ratios). CERs：Defined as the ratio of the total costs of a medical intervention to the health benefits gained from that intervention. ICERs：Defined as the ratio of the difference in costs between two alternative interventions（Arm A and Arm B） to the difference in their effectiveness.
Assessment of quality of life through the Quality of Life Questionnaire (QLQ)